Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics Statistics

Total Valuation

KYTX has a market cap or net worth of $431.58 million. The enterprise value is $72.07 million.

Market Cap	431.58M
Enterprise Value	72.07M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

KYTX has 43.12 million shares outstanding. The number of shares has increased by 5,115.19% in one year.

Shares Outstanding	43.12M
Shares Change (YoY)	+5,115.19%
Shares Change (QoQ)	+2,881.87%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.20
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.17, with a Debt / Equity ratio of 0.03.

Current Ratio	17.17
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$790,792
Employee Count	96
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	11.25
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.76
Average Volume (20 Days)	632,150

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	-75.92M
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	-$1.76

Balance Sheet

The company has $370.36 million in cash and $10.85 million in debt, giving a net cash position of $359.52 million or $8.34 per share.

Cash & Cash Equivalents	370.36M
Total Debt	10.85M
Net Cash	359.52M
Net Cash Per Share	$8.34
Equity (Book Value)	360.99M
Book Value Per Share	8.37
Working Capital	353.62M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KYTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5,115.19%
Shareholder Yield	-5,115.19%
Earnings Yield	-17.59%
FCF Yield	n/a

Analyst Forecast

The average price target for KYTX is $29.00, which is 189.71% higher than the current price. The consensus rating is "Buy".

Price Target	$29.00
Price Target Difference	189.71%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-43.63%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2